David Shalowitz, MD, MSHP is a board-certified gynecologic oncologist and Director for Health Equity and Community Outreach at West Michigan Cancer Center Radiation & Surgical Specialties.

Dr. Shalowitz attended medical school at the University of Michigan and completed his residency in obstetrics and gynecology at Brigham and Women’s/Massachusetts General Hospitals.  He then received subspecialty training in gynecologic oncology and a master’s degree in health policy research from the University of Pennsylvania.  Dr. Shalowitz also completed a fellowship in clinical bioethics at the National Institutes of Health.

Dr. Shalowitz is an expert in the treatment of malignancies of the female reproductive tract, as well as complex gynecologic surgical care for non-cancerous conditions.  He offers minimally invasive and same-day surgical options, when appropriate, and is committed to working with patients to provide the highest quality care while making sure that all aspects of their lives are considered.  He feels privileged to work with patients in southwestern Michigan and accompany them through diagnosis, treatment, and survivorship.

Dr. Shalowitz is a nationally recognized researcher in health equity and access to gynecologic cancer care, and brings this background to his role as Director for Health Equity and Community Outreach at WMCC.  He is particularly invested in helping patients who live in rural areas in the United States overcome barriers to receiving high-quality cancer care, and is excited to focus his efforts on patients treated in southwestern Michigan.  Dr. Shalowitz is a past Chair of the Committee on Ethics for the American College of Obstetricians and Gynecologists, and continues his research into the intersection between ethics and health policy related to access to cancer care.  A selection of his scholarly work is available here .  Dr. Shalowitz also leads the Collaborative on Equity in Rural Cancer Care (CERCC), a national, multidisciplinary group of researchers committed to improving health equity for rural patients with cancer.

In 2024, Dr. Shalowitz was elected to the Board of Directors of the American College of Obstetricians and Gynecologists (ACOG) as a representative of the Society of Gynecologic Oncology.

• Medical School
  University of Michigan
  Ann Arbor, MI
• Residency
  Obstetrics and Gynecology
  Brigham and Women’s Hospital/Massachusetts General Hospital
  Boston, MA
• Fellowship
  Gynecologic Oncology
  University of Pennsylvania
  Philadelphia, PA
• Fellowship
  Clinical Bioethics
  National Institutes of Health
  Bethesda, MD
• Master of Health Policy Research
  University of Pennsylvania
  Philadelphia, PA
• Board Certification
  Obstetrics and Gynecology
  Gynecologic Oncology

• Ovarian cancer
• Uterine cancer
• Vulvar cancer
• Gestational trophoblastic disease
• Cervical cancer
• Placenta accreta spectrum disorders